Kelai Pharmaceutical: drug development partnership with Nutrasource
Kelai Phamraceutical has partnered with contract research organization Nutrasource Pharmaceutical to support its early-stage drug development program. The company specializes in botanicals, including the kava plant and its derivatives.
“Navigating the regulatory pathway for a new drug is no simple task,” said Jacqueline Jacques, Kelai Pharmaceutical CEO. “Kelai is happy to have an FDA regulatory partner with significant expertise in both natural compounds and pharmaceuticals to support us in plotting this course. This will let us be laser-focused on the most important tasks – minimizing our risk and optimizing our efforts from the earliest stages of development.”